Deborah J. Marshall - Concepedia

Author

Deborah J. Marshall

Johnson & Johnson (United States)

Also Known As

Deborah J Marshall, Deborah J. Marshall

Publications

650

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)CSL (United States)

About

Deborah J. Marshall is an author at Johnson & Johnson (United States) specializing in medicine, immunology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	248
2	Immunology	6	6	198
3	Cell Biology	3	3	92
4	Pharmacology	2	2	75
5	Radiation Medicine	1	1	56

Deborah J. Marshall

Publications

610

Citations

H-Index

Page 1

	Year	Citations
Efficient and Stable Transduction of Cardiomyocytes After Intramyocardial Injection or Intracoronary Perfusion With Recombinant Adeno-Associated Virus Vectors E. C. Svensson, Deborah J. Marshall, Karen Woodard, Circulation	1999	220
Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor–positive breast carcinoma models Kenneth R. LaMontagne, Jeannene Butler, Deborah J. Marshall, Molecular Cancer Therapeutics	2006	81
Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine Deborah J. Marshall, Kelly A. Rudnick, Stephen G. McCarthy, Vaccine VaccinationTumor ProtectionCancer ImmunosurveillanceImmunologyTumor Immunity	2005	67
Anti–αv Integrin Monoclonal Antibody Intetumumab Enhances the Efficacy of Radiation Therapy and Reduces Metastasis of Human Cancer Xenografts in Nude Rats Shoucheng Ning, Junqiang Tian, Deborah J. Marshall, Cancer Research ImmunologyHuman Cancer XenograftsImmunotherapyTumor BiologyNude Rats	2010	56
Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model Yelin Wu, Leslie L. Muldoon, Seymur Gahramanov, Journal of Neuro-Oncology Tumor BiologyMedicineCancer Cell BiologyBreast CancerTumor Targeting	2012	50
Biocompatibility of Cardiovascular Gene Delivery Catheters with Adenovirus Vectors: An Important Determinant of the Efficiency of Cardiovascular Gene Transfer Deborah J. Marshall, Maria Palasis, John J. Lepore, Molecular Therapy	2000	46
Integrin receptors on tumor cells facilitate NK cell‐mediated antibody‐dependent cytotoxicity Nadia Anikeeva, Maria Steblyanko, Svetlana Fayngerts, European Journal of Immunology Tumor ImmunologyCancer ImmunosurveillanceCnto 95LfMedicineCd16.nk-92 Cells	2014	23
Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine Deborah J. Marshall, Lani R. San Mateo, Kelly A. Rudnick, Cancer Immunology Immunotherapy VaccinationTumor ProtectionCancer ImmunosurveillanceImmunologyTumor Immunity	2005	23
Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer Jingquan Jia, Alex Starodub, Ian Cushman, Anti-Cancer Drugs ImmunologySrc PathwaysCancer BiologyTumor BiologyOncology	2012	19
Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti – αV-Integrin Antibody Marta Bellone, Emiliano Cocco, Joyce Varughese, International Journal of Gynecological Cancer	2011	15

Page 1